Rapid and highly sensitive liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantitation of buspirone in human plasma: Application to a pharmacokinetic study

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 8, 2006, Pages 1293-1298

  Cho, Sung Hee ^a   Lee, Heon Woo ^a   Im, Ho Taek ^a   Park, Wan Su ^a   Choi, Young Wook ^b   Rew, Jae Hwan ^c   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Chung Ang University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MASS SPECTROMETRY; PLASMA (HUMAN);

ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN PLASMAS; LC-ESI-MS/MS; LC/ESI-MS/MS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID-LIQUID EXTRACTION; PHARMACOKINETIC STUDIES; PLASMA SAMPLES; RAPID METHOD; SENSITIVE METHOD;

PHARMACOKINETICS;

EID: 33645842226     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2441     Document Type: Article

References (20)

1. Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW. J. Med. Chem. 1972; 15: 477.
2. Goldberg H. Pharmacotherapy 1994; 4: 315.
3. Krysiak R, Obuchowicz E, Herman ZS. Neur. Res. 1999; 35: 291.
4. Chilmonckyk Z, Ksycinska H, Cybulski J, Wozniakowska-Szelejewska A. Die Pharm. 1986; 51: 924.
5. Gobert A, Newman-Tancredi A, Rivet JM, Audinot V, Millan MJ. Eur. Neuropsychopharmacol. 1997; 7: S149.
6. Gaillard Y, Gay-Montchamp JP, Ollagnier M. J. Chromatogr. B 1993; 622: 197.
7. Sciacca MA, Duncan GF, Shea JP, Faulkner HC III, Farmen RH, Pittman KA. J. Chromatogr. B 1988; 428: 265.
8. Kerns EH, Bullen WW, Gammans RE. J. Chromatogr. B 1986; 377: 195.
9. Gammans RE, Kerns EH, Bullen WW. J. Chromatogr. B 1985; 345: 285.
10. Foroutan SM, Zarghi A, Shafaati AR, Khoddam A. Il Farmaco 2004; 59: 739.
11. Péhourcq F. Biomed. Chromatogr. 2004; 18: 637.
12. Zaxariou M, Panderi I. J. Pharm. Biomed. Anal. 2004; 35: 41.
13. Odontiadis J, Franklin M. J. Pharm. Biomed. Anal. 1996; 14: 347.
14. Ary K, Róna K, Ondi S, Gachályi B. J. Chromatogr. A 1998; 797: 221.
15. Foroutan SM, Zarghi A, Shafaati AR, Khoddam A. Il Farmaco 2004; 59: 739.
16. Diaz-Marot A, Puigdellivol E, Salvatella C, Comellas L, Gassiot M. J. Chromatogr. B 1989; 490: 470.
17. US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: Bioanalytical Method validation, US Department of Health and Human Services: Rockville, MD, 2001. Website: http://www.fda.gov/cder/guidance/index.htm.
18. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 1998; 70: 882.
19. Fu I, Woolf EJ, Matuszewski BK. J. Pharm. Biomed. Anal. 1998; 18: 347.
20. Korea Food and Drug Administration, Bioequivalence division, Pharmacology Department, National Institute of Toxicology Department, Guidance for Industry: Statistical Approaches to Establishing Bioequivalence, 2003. Website: http://www.kfda.go.kr.